Drug Information

Drug General Information
Drug ID
D0X1JO
Former ID
DIB019860
Drug Name
IN1479
Synonyms
IN1479
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528317]
Structure
Download
2D MOL
Formula
C21H23N3OS
InChI
InChI=1S/C21H23N3OS/c1-2-6-17(7-3-1)20-16-22-21(26-20)23-18-8-10-19(11-9-18)25-15-14-24-12-4-5-13-24/h1-3,6-11,16H,4-5,12-15H2,(H,22,23)
InChIKey
FNZTULJDGIXMJJ-UHFFFAOYSA-N
PubChem Compound ID
11772958
PubChem Substance ID
16882184, 23850738, 26758703, 42814921, 53800919, 78853667, 99302689, 139788425, 141062211, 163333080, 163688140, 175607407, 178102595, 208265126, 224109805, 228357858, 249094585
Target and Pathway
Target(s) FL cytokine receptor Target Info Inhibitor [528317]
KEGG Pathway Cytokine-cytokine receptor interaction
Hematopoietic cell lineage
Pathways in cancer
Transcriptional misregulation in cancer
Acute myeloid leukemia
Central carbon metabolism in cancer
References
Ref 528317Aromatic interactions with phenylalanine 691 and cysteine 828: a concept for FMS-like tyrosine kinase-3 inhibition. Application to the discovery of a new class of potential antileukemia agents. J MedChem. 2006 Jul 27;49(15):4451-4.
Ref 528317Aromatic interactions with phenylalanine 691 and cysteine 828: a concept for FMS-like tyrosine kinase-3 inhibition. Application to the discovery of a new class of potential antileukemia agents. J MedChem. 2006 Jul 27;49(15):4451-4.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.